Treatment for Psychosis

Phase-Based Progress Estimates
New York State Psychiatric Institute, New York, NYPsychosis
16 - 30
All Sexes
What conditions do you have?

Study Summary

This trial aims to develop two clinical tools to help high-risk youth make healthy choices by using a genetic malleability framing.

Eligible Conditions
  • Psychosis

Treatment Effectiveness

Study Objectives

2 Primary · 4 Secondary · Reporting Duration: 15 minutes

15 minutes
Behavioral Measure for Intent to Engage in Treatment
Implicit Association Test
Increased Intent to Engage in Treatment and Healthy Behaviors
5 minutes
Anticipated Discrimination from Others Due to Genetic Risk for Psychosis Development
Anticipated Rejection from Others Due to Genetic Risk for Psychosis Development
Self-Stigma About Genetic Risk for Psychosis Development

Trial Safety

Trial Design

0 Treatment Group

25 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · Phase 1

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 15 minutes

Who is running the clinical trial?

New York State Psychiatric InstituteOTHER
461 Previous Clinical Trials
149,010 Total Patients Enrolled
7 Trials studying Psychosis
950 Patients Enrolled for Psychosis
New York UniversityLead Sponsor
207 Previous Clinical Trials
314,097 Total Patients Enrolled
2 Trials studying Psychosis
424 Patients Enrolled for Psychosis
Lawrence Yang, PhDPrincipal InvestigatorNew York University

Eligibility Criteria

Age 16 - 30 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Do I meet the criteria to participate in this experiment?

"This clinical research is recruiting 54 individuals aged 16-30 who currently have psychosis and fit into one of the three categories listed under atteneded positive symptoms. Furthermore, all interested candidates must be (or recently had been) participants in COPE." - Anonymous Online Contributor

Unverified Answer

Does the inclusion criteria for this research project include those aged sixty and above?

"This clinical study has particular requirements for qualified applicants; they must be between 16 and 30 years old. There are 116 trials specifically recruiting minors and 262 trials that cater to elderly patients." - Anonymous Online Contributor

Unverified Answer

What is the targeted cohort for this clinical research?

"Affirmative. The clinical trial website,, reports that the research is actively recruiting with 54 patients needing to be recruited from one medical centre. This study was first posted on November 16th 2020 and most recently updated June 6th 2022." - Anonymous Online Contributor

Unverified Answer

Is the research team actively seeking participants for this experiment?

"As confirmed by, this medical trial is actively in search of participants. The initial post was on the 16th November 2020 and it has since been revised at least once as of 6 June 2022." - Anonymous Online Contributor

Unverified Answer

What aims has this trial been designed to achieve?

"The primary focus of this 15-minute clinical trial is to measure Behavioral Intent towards Engaging in Treatment. Secondary outcomes include Anticipated Rejection and Discrimination from Others Due to Genetic Risk for Psychosis Development, which are both based on published scales (Link et al., 2015; Wahl, 1999). Additionally, an Implicit Association Test will be performed to assess participants' associations between 'Normal/Abnormal' and 'Changeable/Permanent'. As it is an exploratory R21 study, the investigators have constructed new measures as well." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.